| Document Date: 2013-09-23 22:29:54
Open Document File Size: 121,08 KBShare Result on Facebook
City Tokyo / / Company Teva Pharmaceutical Industries Ltd. / Cima Labs Inc. / Cephalon Inc. / Teikoku Seiyaku Co. Ltd. / Taiho Pharmaceutical Co. Ltd. / / Continent Europe / / Country Japan / United States / / Currency JPY / / Event Business Partnership / FDA Phase / M&A / / IndustryTerm appropriate inf ormation / manufacturing / pharmaceutical / therapy for their underlying persistent cancer / / MedicalCondition cancer / persistent cancer / continuous cancer / each breakthrough pain / pain / breakthrough pain / / Organization Japan NHI / / Person Misako Fujioka / Masayuki Kobayashi / / Position President / President & CEO / / Product E-fen Buccal tablets / fentanyl citrate / Ltd. Cancer Pain Reliever E-fen Buccal Tablets / fentanyl / Buccal / Fentora / Fentora® (USA) / / ProvinceOrState Kagawa Prefecture / /
SocialTag |
News Release September 25, 2013 Taiho Pharmaceutical Co., Ltd. Teikoku Seiyaku Co., Ltd. Cancer Pain Reliever E-fen Buccal Tablets Launched